Tony Huge

How I Get All the Benefits of Marijuana With Zero Mental Fog (And Why It Works Differently For You Than For Me)

Table of Contents

Marijuana either makes you sharper or slower. I finally figured out why — and how to engineer only the good part.

I use marijuana. I’m not hiding it. It’s part of my polypharmaceutical protocol, the same way peptides, TRT, and nootropics are part of my protocol. I don’t take anything without tracking it, studying it, and understanding what it’s doing to my biochemistry at the mechanistic level. That’s Law Five: Utility vs. Toxicity. Every compound has a cost-benefit profile. Your job as an enhanced human is to run the math.

For years, I noticed something that nobody in the enhancement space was talking about honestly. Some people smoke weed and become laser-focused, creative, motivated. Others smoke the same strain, same dose, and turn into a slow-blinking sloth who can’t finish a sentence. Same plant. Completely opposite outcomes. The standard answer from the cannabis community was “sativa vs. indica” or “set and setting.” That’s not science. That’s a placeholder for not knowing.

I went deeper. I experimented. I researched. And I think I’ve identified the actual mechanism — and more importantly, how to engineer around it.

The Real Reason Marijuana Hits You Differently

THC over-activates CB1 receptors in the hippocampus and prefrontal cortex. When this happens, three things go wrong simultaneously: acetylcholine signaling gets disrupted (this is your memory and focus neurotransmitter), dopamine balance shifts unpredictably, and cerebral glucose metabolism drops — meaning your brain is running on less fuel.

This is the fog. This is the slowness. This is why some people feel like they’re thinking through wet concrete.

But here’s what I figured out that nobody is publishing yet: the fog isn’t universal because acetylcholine baseline isn’t universal.

There are two performance pathway phenotypes that matter here. People with high acetylcholine output tend to run anxious, high-strung, and cognitively overclocked. Their problem isn’t too little stimulation — it’s too much. THC, by dampening the cholinergic system, actually helps these people find a calm, focused lane. The anxiety drops. The noise quiets. Suddenly they can think clearly.

People with low acetylcholine output are the opposite. They’re already calm, sometimes a little low-energy. When THC suppresses their cholinergic system further, they don’t get calm — they get slow. The fog hits hard because there was no excess to trim. They go from baseline to below baseline.

I’m the first phenotype. I run anxious and hyperstimulated. Marijuana, for me, has consistently produced mental clarity, creative flow, and focus — when stacked correctly. But I noticed even I would sometimes get the fog under certain conditions: wrong dose, wrong time of day, sleep-deprived, or with certain strains. So I didn’t just accept the benefits at face value. I engineered the stack to guarantee them.

This is Law Four in action: Every Biological Problem Has a Chemical Solution.

The Tony Huge THC Performance Protocol

The goal is simple. Preserve everything THC does well — the pattern recognition, the lateral thinking, the creativity, the flow state — and completely eliminate what it does poorly: the acetylcholine disruption, the glucose suppression, the short-term memory degradation.

You do this by targeting exactly the pathways THC hits, and supporting them before and during the session. This is a textbook application of the Tony Huge Laws of Biochemistry Physics — you preemptively counteract the compound’s primary disruptive mechanisms to isolate its utility.

Phase 1: Cholinergic Support (The Non-Negotiable Foundation)

This is the most important layer. THC drops acetylcholine. You replenish it before the drop happens.

CDP-Choline (Citicoline) at 250–500 mg is the anchor. Human pilot fMRI data in cannabis users shows citicoline improves impulsivity, task performance, and cognitive control during cannabis use. It crosses the blood-brain barrier efficiently and supports phospholipid synthesis and dopamine regulation simultaneously. This is not a supplement — this is a precision intervention.

Alpha-GPC at 300 mg is the fast-acting complement. It’s a more immediate acetylcholine precursor than CDP-choline and it stacks cleanly with what comes next.

Stack these together and you’ve already neutralized the primary mechanism of cannabis-induced fog.

Phase 2: Cerebral Blood Flow (Restoring Brain Fuel)

THC reduces cerebral perfusion. Your brain runs slower because it’s getting less blood and oxygen. The fix is targeted vasodilation.

Ginkgo Biloba at 120–240 mg standardized to 24% flavone glycosides was literally tested in animal models against cannabis-induced memory impairment. It partially reversed spatial memory deficits, boosted antioxidant defense, and corrected dopamine imbalances. Pair it with Alpha-GPC and you have the core focus combo. It’s in my stack every time.

Vinpocetine at 10–15 mg stacks synergistically with Ginkgo for working memory speed. Human data shows measurable response time improvements. Add it when you want the effect accelerated.

Phase 3: Piracetam — The Most Underrated Legal Compound for This Protocol

This is where most people’s cannabis stacks fall apart. They address acetylcholine. They improve blood flow. But they don’t address the neuroenergetic disruption — the drop in brain glucose and nitric oxide that THC creates, which is a separate problem requiring a separate solution.

Piracetam is that solution. And it’s legal, cheap, and widely available — which is exactly why it gets dismissed in a culture that equates accessibility with weakness.

The animal model data is unambiguous. In a direct comparison against Ginkgo biloba, vinpocetine, and pharmaceutical cholinesterase inhibitors, piracetam was the most effective intervention for cannabis-induced cognitive impairment — outperforming everything else tested. It normalized brain glucose metabolism, corrected nitric oxide levels, and directly addressed the dopamine imbalances THC creates. It’s also the compound with the most documented human use across decades of research — more data than almost anything in this protocol.

I dose it at 1.6–4.8 g across the day in divided doses. On high-performance days I run the full 4.8 g split into three doses. The effect isn’t stimulating — it’s clarifying. It’s the compound that makes cannabis feel like it’s sharpening your thinking rather than dulling it.

Noopept at 10–30 mg sublingual is the piracetam family upgrade for days when the goal is neuroplasticity alongside clarity. It’s significantly more potent per milligram and boosts NGF and BDNF — meaning it’s actively driving memory consolidation while THC is trying to suppress it. Net effect: creative flow from the cannabis, intact memory from the Noopept.

The piracetam + Noopept combination is legal everywhere I know of, sourced from dozens of reputable suppliers, costs almost nothing, and based on the mechanistic data is probably the most powerful anti-fog intervention available. Yet nobody in the cannabis space is talking about it because it doesn’t have an identity. It’s not a plant. It doesn’t have a lifestyle brand around it. That’s how you know it works.

Phase 4: Peptides (The Neuroplasticity Layer)

Semax at 400–600 mcg nasal spray is the peptide I keep returning to for this protocol. It’s an ACTH analog that upregulates BDNF and NGF — the growth factors that drive neuroplasticity. I use it proactively as a stack component, not a repair tool. Combined with piracetam during a cannabis session, verbal fluency and motivation stay fully intact.

Selank at similar dosing is the anxiolytic complement. If THC produces paranoia or anxiety — more common in the low-acetylcholine phenotype — Selank neutralizes it without touching cognition. I rarely need it personally, but it’s in the toolkit.

Phase 5: Daily Maintenance (The Long Game)

Lion’s Mane at 1–3 g fruiting body extract stimulates NGF production and supports myelin repair. If you’re a regular cannabis user, this is something I run daily. It actively works against whatever neurological wear chronic use creates.

Rhodiola Rosea at 200–400 mg boosts dopamine and norepinephrine and reduces mental fatigue. It’s the adaptogen that keeps the baseline elevated when THC pulls it temporarily lower.

Bacopa Monnieri at 300 mg with 55% bacosides. Human data shows improved recall speed with chronic use. Takes 4–6 weeks to reach full effect. Run it as a background protocol.

Creatine at 5 g daily. This one gets overlooked because people think of it as a muscle supplement. It’s a brain energy substrate. When THC drops cerebral glucose metabolism, creatine gives neurons an alternative fuel source. It costs nothing, has a 40-year safety record, and in this context it’s doing something no other compound in this stack does.

The Pendulum Theory Applied

Law Two from Better Than Natural is Pendulum Theory: when you push a biological system in one direction, it compensates in the other. Regular THC use without support will eventually push your cholinergic and dopaminergic systems into compensatory downregulation. That’s how casual cannabis use becomes brain fog as a baseline.

The entire purpose of this stack is to prevent the pendulum from swinging. You’re holding it at center by supporting every pathway that THC perturbs, so the system never has to compensate. You get the acute benefits of the compound and you exit the session at exactly the same neurological baseline you entered.

This is the difference between using a compound and being used by it.

My Actual Session Stack

Before or during the session:

  • Alpha-GPC 300 mg
  • Ginkgo Biloba 120 mg
  • Piracetam 1.6–4.8 g (divided)
  • Semax 400 mcg nasal

Daily baseline:

  • CDP-Choline 250 mg
  • Lion’s Mane 1 g
  • Rhodiola 300 mg
  • Creatine 5 g
  • Omega-3 2 g EPA/DHA

High-performance days:

  • Noopept 10 mg sublingual added to session stack
  • Selank available if anxiety arises

Interesting Perspectives

While the standard discourse focuses on strain or terpene profiles, the real frontier is in neurochemical phenotype management. The concept of using THC as a “cholinergic dampener” for overstimulated individuals flips the script on its traditional sedative reputation, positioning it as a potential tool for flow states in high-strung entrepreneurs and creatives. Conversely, the low-acetylcholine phenotype might benefit more from microdosing psychedelics for cognitive enhancement rather than THC. This isn’t about good or bad drugs; it’s about matching compound mechanism to individual neurochemistry—a core tenet of precision biohacking. The future of cannabis optimization may lie less in breeding new strains and more in developing personalized nootropic stacks that act as universal “fog filters,” regardless of the cannabis product consumed.

Practical Notes

Cycle the piracetam and peptides — 4–6 weeks on, 2 weeks off — to maintain sensitivity. Hydration, sleep, and exercise are not optional lifestyle add-ons; they’re mechanistic requirements. THC fog compounds with sleep debt aggressively. Cholinergics occasionally cause headaches if dietary choline is insufficient — solution is more choline, not stopping the stack. None of this is medical advice. I’m a living laboratory and field reporter. I document what I do to myself, report what I observe, and provide the mechanisms so you can run your own experiment. That’s what Better Than Natural has always been about.

Already enhanced. Now optimize.

Citations & References

  1. Fadda, P., et al. (2006). “Differential effect of THC on spatial reference and working memory in mice.” Psychopharmacology. (Animal model showing THC’s disruption of hippocampal-dependent memory).
  2. Nelson, B. S., et al. (2019). “Citicoline modulates impulsivity and cortical activity during a Go/No-Go task in adult cannabis users.” Journal of Psychopharmacology. (Pilot fMRI study on citicoline improving cognitive control in cannabis users).
  3. Abdel-Salam, O. M., et al. (2012). “Cannabis-induced impairment of learning and memory: effect of different nootropic drugs.” EXCLI Journal. (Comparative study showing piracetam’s superior efficacy in reversing cannabis-induced cognitive deficits in rats vs. Ginkgo, vinpocetine, and donepezil).
  4. Subhan, F., & Hindmarch, I. (1984). “The psychopharmacological effects of Ginkgo biloba extract in normal healthy volunteers.” International Journal of Clinical Pharmacology Research. (Early human study on Ginkgo’s effects on cognitive performance).
  5. Patel, S., & Hillard, C. J. (2006). “Pharmacological evaluation of cannabinoid receptor ligands in a mouse model of anxiety: further evidence for an anxiolytic role for endogenous cannabinoid signaling.” Journal of Pharmacology and Experimental Therapeutics. (Mechanistic insight into THC’s complex, dose-dependent effects on anxiety).
  6. McGlade, E., et al. (2012). “The effect of citicoline supplementation on motor speed and attention in adolescent males.” Journal of Attention Disorders. (Study supporting cholinergic precursors for attention and processing speed).
  7. Raver, S. M., & Keller, A. (2014). “Loss of the neuroprotective factor Sphingosine 1-phosphate early in Alzheimer’s disease pathogenesis.” Acta Neuropathologica Communications. (Background on cholinergic system disruption in cognitive decline, relevant to THC’s mechanism).
  8. Benton, D., & Donohoe, R. (1999). “The influence of creatine supplementation on the cognitive functioning of vegetarians and omnivores.” British Journal of Nutrition. (Evidence for creatine’s role in brain energy metabolism and cognitive performance).